Cargando…
A Droplet Microfluidic System to Fabricate Hybrid Capsules Enabling Stem Cell Organoid Engineering
Organoids derived from self‐organizing stem cells represent a major technological breakthrough with the potential to revolutionize biomedical research. However, building high‐fidelity organoids in a reproducible and high‐throughput manner remains challenging. Here, a droplet microfluidic system is d...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284190/ https://www.ncbi.nlm.nih.gov/pubmed/32537414 http://dx.doi.org/10.1002/advs.201903739 |
_version_ | 1783544411261501440 |
---|---|
author | Liu, Haitao Wang, Yaqing Wang, Hui Zhao, Mengqian Tao, Tingting Zhang, Xu Qin, Jianhua |
author_facet | Liu, Haitao Wang, Yaqing Wang, Hui Zhao, Mengqian Tao, Tingting Zhang, Xu Qin, Jianhua |
author_sort | Liu, Haitao |
collection | PubMed |
description | Organoids derived from self‐organizing stem cells represent a major technological breakthrough with the potential to revolutionize biomedical research. However, building high‐fidelity organoids in a reproducible and high‐throughput manner remains challenging. Here, a droplet microfluidic system is developed for controllable fabrication of hybrid hydrogel capsules, which allows for massive 3D culture and formation of functional and uniform islet organoids derived from human‐induced pluripotent stem cells (hiPSCs). In this all‐in‐water microfluidic system, an array of droplets is utilized as templates for one‐step fabrication of binary capsules relying on interfacial complexation of oppositely charged Na‐alginate (NaA) and chitosan (CS). The produced hybrid capsules exhibit high uniformity, and are biocompatible, stable, and permeable. The established system enables capsule production, 3D culture, and self‐organizing formation of human islet organoids in a continuous process by encapsulating pancreatic endocrine cells from hiPSCs. The generated islet organoids contain islet‐specific α‐ and β‐like cells with high expression of pancreatic hormone specific genes and proteins. Moreover, they exhibit sensitive glucose‐stimulated insulin secretion function, demonstrating the capability of these binary capsules to engineer human organoids from hiPSCs. The proposed system is scalable, easy‐to‐operate, and stable, which can offer a robust platform for advancing human organoids research and translational applications. |
format | Online Article Text |
id | pubmed-7284190 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72841902020-06-11 A Droplet Microfluidic System to Fabricate Hybrid Capsules Enabling Stem Cell Organoid Engineering Liu, Haitao Wang, Yaqing Wang, Hui Zhao, Mengqian Tao, Tingting Zhang, Xu Qin, Jianhua Adv Sci (Weinh) Communications Organoids derived from self‐organizing stem cells represent a major technological breakthrough with the potential to revolutionize biomedical research. However, building high‐fidelity organoids in a reproducible and high‐throughput manner remains challenging. Here, a droplet microfluidic system is developed for controllable fabrication of hybrid hydrogel capsules, which allows for massive 3D culture and formation of functional and uniform islet organoids derived from human‐induced pluripotent stem cells (hiPSCs). In this all‐in‐water microfluidic system, an array of droplets is utilized as templates for one‐step fabrication of binary capsules relying on interfacial complexation of oppositely charged Na‐alginate (NaA) and chitosan (CS). The produced hybrid capsules exhibit high uniformity, and are biocompatible, stable, and permeable. The established system enables capsule production, 3D culture, and self‐organizing formation of human islet organoids in a continuous process by encapsulating pancreatic endocrine cells from hiPSCs. The generated islet organoids contain islet‐specific α‐ and β‐like cells with high expression of pancreatic hormone specific genes and proteins. Moreover, they exhibit sensitive glucose‐stimulated insulin secretion function, demonstrating the capability of these binary capsules to engineer human organoids from hiPSCs. The proposed system is scalable, easy‐to‐operate, and stable, which can offer a robust platform for advancing human organoids research and translational applications. John Wiley and Sons Inc. 2020-04-11 /pmc/articles/PMC7284190/ /pubmed/32537414 http://dx.doi.org/10.1002/advs.201903739 Text en © 2020 The Authors. Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Communications Liu, Haitao Wang, Yaqing Wang, Hui Zhao, Mengqian Tao, Tingting Zhang, Xu Qin, Jianhua A Droplet Microfluidic System to Fabricate Hybrid Capsules Enabling Stem Cell Organoid Engineering |
title | A Droplet Microfluidic System to Fabricate Hybrid Capsules Enabling Stem Cell Organoid Engineering |
title_full | A Droplet Microfluidic System to Fabricate Hybrid Capsules Enabling Stem Cell Organoid Engineering |
title_fullStr | A Droplet Microfluidic System to Fabricate Hybrid Capsules Enabling Stem Cell Organoid Engineering |
title_full_unstemmed | A Droplet Microfluidic System to Fabricate Hybrid Capsules Enabling Stem Cell Organoid Engineering |
title_short | A Droplet Microfluidic System to Fabricate Hybrid Capsules Enabling Stem Cell Organoid Engineering |
title_sort | droplet microfluidic system to fabricate hybrid capsules enabling stem cell organoid engineering |
topic | Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284190/ https://www.ncbi.nlm.nih.gov/pubmed/32537414 http://dx.doi.org/10.1002/advs.201903739 |
work_keys_str_mv | AT liuhaitao adropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering AT wangyaqing adropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering AT wanghui adropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering AT zhaomengqian adropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering AT taotingting adropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering AT zhangxu adropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering AT qinjianhua adropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering AT liuhaitao dropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering AT wangyaqing dropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering AT wanghui dropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering AT zhaomengqian dropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering AT taotingting dropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering AT zhangxu dropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering AT qinjianhua dropletmicrofluidicsystemtofabricatehybridcapsulesenablingstemcellorganoidengineering |